Status:
COMPLETED
Oat Beta-glucan as a Supplement in Chilean Type 2 Diabetics
Lead Sponsor:
Centro de Estudios en Alimentación y Nutrición, Chile
Conditions:
Type2 Diabetes
Eligibility:
All Genders
Phase:
PHASE2
Brief Summary
Objective: To evaluate the effect of oat β-glucans on the satiety perception, metabolic control and intestinal microbiota of type 2 diabetics from Talca, Chile. Methodology: Clinical trial, controlled...
Eligibility Criteria
Inclusion
- Subjects with type 2 diabetes mellitus
- Use of oral hypoglycemic agents (Metformin)
- 30 to 45 years
- More than one year and less than 10 diabetes
- no major chronic complications
- Hb A1c between 7 to 9%
- BMI between 30-35 Kg / mt2.
Exclusion
- Pregnant women
- Acute and / or chronic intestinal pathologies (malabsorption syndrome, celiac disease, chronic inflammatory bowel diseases, among others.),
- Drugs that interfere with the microbiota (antibiotics, anti-inflammatories, laxatives, prokinetics),
- Organic insufficiencies (cardiac, hepatic, renal, respiratory), or with immunodeficiencies (HIV, chemotherapy, radiotherapy, transplanted).
- Presence of smoking habit.
- Regular probiotic or prebiotic intake (more than 2 months)
- Dipeptidyl peptidase 4 inhibitors (DPP4) and α-amylase inhibitor drugs.
Key Trial Info
Start Date :
June 19 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 18 2019
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT04299763
Start Date
June 19 2018
End Date
January 18 2019
Last Update
March 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro de Estudios en Alimentación y Nutrición
Talca, Maule Region, Chile, 3480428